Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury-Reference-Cited by-同舟云学术

Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury

Published:2023-02 Issue: Volume:59 Page:102589
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Sun Dandan,Chen Shimei,Li Shenping,Wang Ning,Zhang Shuchang,Xu Li,Zhu Shaopin,Li Huiming,Gu Qing,Xu Xun,Wei Fang

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference72 articles.

1. Global trends in diabetes complications: a review of current evidence;Harding;Diabetologia,2019

2. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas;Saeedi,2019

3. Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond;Hammes;Diabetologia,2018

4. The pathobiology of diabetic complications: a unifying mechanism;Brownlee;Diabetes,2005

5. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells;Du;J. Clin. Invest.,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UCP2–SIRT3 Signaling Relieved Hyperglycemia-Induced Oxidative Stress and Senescence in Diabetic Retinopathy;Investigative Opthalmology & Visual Science;2024-01-04

2. Upper glycolytic components contribute differently in controlling retinal vascular endothelial cellular behavior: Implications for endothelial-related retinal diseases;PLOS ONE;2023-11-30

3. Role of glycolysis in diabetic atherosclerosis;World Journal of Diabetes;2023-10-15

4. RNA-sequencing analysis reveals the potential mechanism by which a Dioscorea polystachya (Chinese yam) protein ameliorates hyperglycemia-induced endothelial dysfunction;2023-09-06

5. PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway;Biomolecules;2023-07-03